Rhythm Pharmaceuticals
RYTM
#2252
Rank
$8.25 B
Marketcap
$119.04
Share price
2.08%
Change (1 day)
18.44%
Change (1 year)

P/S ratio for Rhythm Pharmaceuticals (RYTM)

P/S ratio as of November 2026 (TTM): 29.4

According to Rhythm Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 38.0. At the end of 2026 the company had a P/S ratio of 22.7.

P/S ratio history for Rhythm Pharmaceuticals from 2017 to 2026

PS ratio at the end of each year

Year P/S ratio Change
202622.7-38.59%
202536.940.67%
202426.3-25.17%
202335.1-49.46%
202269.4-56.37%
2021159
2020N/A
2019N/A
2018N/A
2017N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA